<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002826" GROUP_ID="MUSKEL" ID="904500080808150963" MERGED_FROM="" MODIFIED="2011-09-06 12:24:38 -0400" MODIFIED_BY="Jordi Pardo Pardo" REVIEW_NO="C090-R" REVMAN_SUB_VERSION="5.1.4" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2011-09-06 12:22:24 -0400" MODIFIED_BY="Jordi Pardo Pardo">
<TITLE>Thermotherapy for treating rheumatoid arthritis</TITLE>
<CONTACT>
<PERSON ID="13312" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Vivian</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Welch</LAST_NAME>
<SUFFIX/>
<POSITION>Research Associate</POSITION>
<EMAIL_1>vivian.welch@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Centre for Global Health, Institute of Population Health</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart Street, Room 206</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562-5800 ext: 2921</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613 562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2011-09-06 12:22:24 -0400" MODIFIED_BY="Jordi Pardo Pardo">
<PERSON ID="13312" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Vivian</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Welch</LAST_NAME>
<SUFFIX/>
<POSITION>Research Associate</POSITION>
<EMAIL_1>vivian.welch@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Centre for Global Health, Institute of Population Health</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart Street, Room 206</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562-5800 ext: 2921</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613 562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="9058" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Lucie</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Brosseau</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>Lucie.Brosseau@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613-562-5800 ext: 8015</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14913" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Lynn</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Casimiro</LAST_NAME>
<SUFFIX/>
<POSITION>Full Time Lecturer</POSITION>
<EMAIL_1>casimiro@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL>www.uottawa.ca</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 8129</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7D89FCA582E26AA20029B854A42545FC" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Maria</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Judd</LAST_NAME>
<SUFFIX>MSc</SUFFIX>
<POSITION>Senior Program Officer</POSITION>
<EMAIL_1>maria.judd@chsrf.ca</EMAIL_1>
<EMAIL_2>mgjudd@yahoo.ca</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Research Use/Agente principale de programme, Utilisation de la Recherche</DEPARTMENT>
<ORGANISATION>Canadian Health Services Research Foundation/Fondation canadienne de la recherche sur les services de santé</ORGANISATION>
<ADDRESS_1>1565 avenue Carling Avenue</ADDRESS_1>
<ADDRESS_2>Suite/pièce 700</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Z 8R1</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-728-2238 ext/poste 250</PHONE_1>
<PHONE_2/>
<FAX_1>613-728-3527</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5440" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Beverley</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Shea</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>bevshea@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>CIET, Institute of Population Health</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart St.</ADDRESS_1>
<ADDRESS_2>Room 312</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 562 5800 ext: 8571</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5474" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Tugwell</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Medicine &amp; Epidemiology and Community Medicine, Canada Research Chair in Health Equity</POSITION>
<EMAIL_1>tugwell.bb@uottawa.ca</EMAIL_1>
<EMAIL_2>kerry.obrien@uottawa.ca</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Medicine</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>1 Stewart Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1N 6N5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext: 1945</PHONE_1>
<PHONE_2/>
<FAX_1>613-562-5659</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12662" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>George</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Wells</LAST_NAME>
<SUFFIX>PhD, MSc</SUFFIX>
<POSITION>Director, Cardiovascular Research Methods Centre</POSITION>
<EMAIL_1>gawells@ottawaheart.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Epidemiology and Community Medicine</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>Room H1-1</ADDRESS_1>
<ADDRESS_2>40 Ruskin Street</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4W7</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 798 5555 x18640</PHONE_1>
<PHONE_2>+1 613 798 5555 x18642</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-09 19:42:42 -0500" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="5" MONTH="12" YEAR="2001"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="5" MONTH="12" YEAR="2001"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="11" YEAR="2008"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR=""/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2002"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-09 19:48:45 -0500" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-11-09 19:48:45 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
<P>CMSG ID: C090-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-11-09 19:49:30 -0500" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Ottawa Health Research Institute</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Institute for Population Health, University of Ottawa</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-09-06 12:24:38 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-09-06 12:24:38 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2011-09-06 12:24:30 -0400" MODIFIED_BY="[Empty name]">Thermotherapy (heat treatment) for treating rheumatoid arthritis</TITLE>
<SUMMARY_BODY MODIFIED="2011-09-06 12:24:38 -0400" MODIFIED_BY="[Empty name]">
<P>Thermotherapy is a commonly used modality in treating rheumatoid arthritis (RA). Thermotherapy modalities include superficial moist heat fomentations (hot packs) at different temperatures, cryotherapy (ice packs), paraffin wax baths and faradic baths. All studies included in this review (n=7) are randomized controlled trials (RCT). </P>
<P>This review found there were no significant effects for hot and ice packs applications and faradic baths on objective measures of disease activity including joint swelling, pain, medication intake, range of motion (ROM), grip strength, hand function or patient preference compared to control (no treatment) or active therapy. However, there were positive results for paraffin wax baths alone for arthritic hands on objective measures of ROM, pinch function, grip strength, pain on non-resisted motion, stiffness compared to control (no treatment) after four consecutive weeks of treatment.</P>
<P>There is no significant difference between wax and therapeutic ultrasound or between wax and faradic bath combined with ultrasound for any of the outcomes measures. The reviewers concluded that thermotherapy can be used as a palliative therapy or as an adjunct therapy combined with exercises for RA patients. Wax baths appear especially helpful in the treatment of arthritic hands. These conclusions are limited by methodological considerations such as the poor quality of trials.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Thermotherapy is often used as adjunct in the treatment of rheumatoid arthritis (RA) by rehabilitation specialists.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To evaluate the effectiveness of different thermotherapy applications on objective and subjective measures of disease activity in patients with RA.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched MEDLINE, EMBASE, Pedro, Current Contents, Sports Discus and CINAHL up to and including September 2001. The Cochrane Field of Rehabilitation and Related Therapies and the Cochrane Musculoskeletal Review Group were also contacted for a search of their specialized registers. Hand searching was conducted on all retrieved articles for additional articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Comparative controlled studies, such as randomized controlled trials, controlled clinical trials, cohort studies or case/control studies, of thermotherapy compared to control or active interventions in patients with RA were eligible. No language restrictions were applied. Abstracts were accepted.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two independent reviewers identified potential articles from the literature search (VR, LB). These reviewers extracted data using pre-defined extraction forms. Consensus was reached on all data extraction. Quality was assessed by two reviewers using a 5 point scale that measured the quality of randomization, double-blinding and description of withdrawals.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Seven studies (n=328 participants) met the inclusion criteria. The results of this systematic review of thermotherapy for RA found that there was no significant effect of hot and ice packs applications (Ivey 1994), cryotherapy (Rembe 1970) and faradic baths (Hawkes 1986) on objective measures of disease activity including joint swelling, pain, medication intake, range of motion (ROM), grip strength, hand function compared to a control (no treatment) or active therapy. </P>
<P>There is no significant difference between wax and therapeutic ultrasound as well as between wax and faradic bath combined to ultrasound for all the outcomes measured after one, two or three week(s) of treatment (Hawkes 1986). There was no difference in patient preference for all types of thermotherapy. No harmful effects of thermotherapy were reported. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Superficial moist heat and cryotherapy can be used as palliative therapy. Paraffin wax baths combined with exercises can be recommended for beneficial short-term effects for arthritic hands. These conclusions are limited by methodological considerations such as the poor quality of trials.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-09 19:52:28 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>Superficial moist heat and cryotherapy are commonly used in physical rehabilitation for patients with rheumatoid arthritis (RA) to relieve pain (<LINK REF="STD-Oosterveld-1992c" TYPE="STUDY">Oosterveld 1992c</LINK>). Both can be easily applied at home by the patient but may also be combined with other rehabilitation interventions.</P>
<P>Thermotherapy is suggested as a potential intervention for the treatment of musculoskeletal conditions in the American Physical Therapy Association guidelines (<LINK REF="REF-APTA-2001" TYPE="REFERENCE">APTA 2001</LINK>). These guidelines are not based on evidence from comparative controlled trials. The Philadelphia Panel (<LINK REF="REF-Philadelphia-2001" TYPE="REFERENCE">Philadelphia 2001</LINK>) developed Evidence Based Clinical Practice Guidelines for several musculoskeletal conditions (<LINK REF="REF-Philadelphia-2001" TYPE="REFERENCE">Philadelphia 2001</LINK>). However, rheumatoid arthritis was not included in these guidelines. Clinicians require good evidence in order to make an informed decision regarding effective and appropriate treatment options. </P>
<P>There are several potentially beneficial physiological and clinical effects of thermotherapy for RA patients. Thermotherapy has effects on pain, muscle spasms, circulation and inflammation (<LINK REF="REF-Knight-1995" TYPE="REFERENCE">Knight 1995</LINK>). Furthermore, it can be applied by patients in their own home as needed. Despite the widespread use of heat and cold by patients with RA for the control of pain, this clinical application is solely based on empiric evidence. In fact, the effectiveness of heat or cold (i.e. cryotherapy) application relative to a placebo, to alternate therapies or even its role as an adjunct remains unclear.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To evaluate the effectiveness of thermotherapy compared to placebo and to other alternate interventions on pain relief for treating patients with RA.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-09 19:52:28 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>According to an a priori protocol, all comparative controlled trials, including randomized controlled trials (RCT), controlled clinical trials(CCT), and case-control and cohort studies were included. Trials which used the same patients as their own control were not accepted. The results were graded according to the strength of the study design.</P>
<P>No language limitations were imposed. Abstracts were accepted.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Adult patients with classic or definite rheumatoid arthritis (<LINK REF="REF-Arnett-1988" TYPE="REFERENCE">Arnett 1988</LINK>) treated with heat or/and cryotherapy or other alternate thermotherapy modalities. All peripheral joints were considered while axial joints of the spine were excluded from the results of this review.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Acceptable interventions included any form of heat (e.g. hot packs, paraffin wax bath) or cryotherapy (e.g. ice packs, cold gel packs). Balneotherapy was excluded as it has been evaluated in another Cochrane review (<LINK REF="REF-Verhagen-2000" TYPE="REFERENCE">Verhagen 2000</LINK>). Acceptable control groups were placebo, untreated, or alternate interventions such as paraffin wax baths, faradic baths and other forms of rehabilitation interventions.<BR/>Concurrent interventions (e.g. NSAIDs, exercises) were accepted if they were given to both comparative groups.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>The primary outcome considered was pain. Secondary outcomes were selected from the potential core set identified by the Outcome Measures in Rheumatology Clinical Trials (OMERACT) conference on RA outcomes (<LINK REF="REF-OMERACT-1993" TYPE="REFERENCE">OMERACT 1993</LINK>). Our final set of secondary outcomes included:</P>
<P>Tender joint count<BR/>Swollen joint count<BR/>Physician global assessment<BR/>Patient global assessment<BR/>Functional status</P>
<P>In addition, two outcomes often used as measures of clinical effects in the practice of rehabilitation were included:<BR/>Range of Motion (ROM)<BR/>Strength</P>
<P>Physiological outcomes such as skin and joint temperature were not included in the analysis.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-09 19:52:28 -0500" MODIFIED_BY="[Empty name]">
<P>The literature search was conducted up to September 2001 according to the sensitive search strategy for RCTs designed for the Cochrane Collaboration (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>), with modifications proposed by Haynes et al (<LINK REF="REF-Haynes-1994" TYPE="REFERENCE">Haynes 1994</LINK>). Additional terms for study design were used to identify observational studies including: case-control, cohort, comparative study and clinical trial. MEDLINE, EMBASE, HealthSTAR, Sports Discus, CINAHL, the Cochrane Controlled Trials Register, Pedro, the specialized registry of the Cochrane Musculoskeletal Group and the Cochrane Field of Rehabilitation and Related Therapies were searched using a keyword and text word search strategy (shown in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). In addition, the reference lists of included trials were searched and content experts were contacted for additional studies.</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Two independent reviewers (VR, LB) examined the titles and abstracts of the trials identified by the search strategy to select trials that met the inclusion criteria. All trials classified as relevant by at least one of the reviewers were retrieved. The retrieved articles were re-examined to ensure they met the inclusion criteria. </P>
<P>The results of the individual trials were extracted from each of the included trials using pre-determined extraction forms by two independent reviewers (LB, VR). The data was cross-checked by a third reviewer (BS). The extraction forms were developed and pilot-tested, based on other forms used by the Cochrane Musculoskeletal Review Group. The extraction form documented specific information about the heat or cold therapy including 1) method (hot pack, paraffin wax, cold water); 2) therapeutic application (duration, frequency, temperature, total number of sessions and any specific skin preparation). The final data values were based on consensus of the two reviewers. </P>
<P>Statistical Analysis<BR/>Most outcomes were continuous in nature (functional status, pain and strength). Where pooling of data from different trials was possible, these outcomes were analyzed using a weighted mean difference (WMD) a fixed effects model. For dichotomous data, relative risks were used. The effect measured in an individual trial is weighted by the amount of variability about the mean (measured by the standard deviation) in that study for that outcome. Graphical data was used in cases where table data was not available.</P>
<P>When applicable, heterogeneity was assessed with a Chi square test on N degrees of freedom where N is the number of studies. Where statistically significant heterogeneity existed, the results were analyzed by a random effects model. Furthermore, the contributions of pre-determined hypotheses regarding different populations and interventions were examined as possible sources of heterogeneity.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>The literature search and handsearching identified 306 potential articles. Of these, seven RCTs were included involving 328 RA patients (<LINK REF="STD-Bulstrode-1986" TYPE="STUDY">Bulstrode 1986</LINK>, <LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>, <LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>, <LINK REF="STD-Ivey-1994" TYPE="STUDY">Ivey 1994</LINK>, <LINK REF="STD-Kirk-1968" TYPE="STUDY">Kirk 1968</LINK>, <LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>, <LINK REF="STD-Williams-1986" TYPE="STUDY">Williams 1986</LINK>). </P>
<P>Fifteen trials were excluded for several reasons: 1) <LINK REF="STD-Abramson-1964" TYPE="STUDY">Abramson 1964</LINK>: no clinical outcomes; 2) <LINK REF="STD-Amundson-1979" TYPE="STUDY">Amundson 1979</LINK>: not a clinical trial; 3) <LINK REF="STD-Bromley-1994" TYPE="STUDY">Bromley 1994</LINK>: sample of healthy people; 3) <LINK REF="STD-Curkovic-1993" TYPE="STUDY">Curkovic 1993</LINK>: no sufficient statistical data; 4) <LINK REF="STD-Devereaux-1985" TYPE="STUDY">Devereaux 1985</LINK>: no control group; 5) <LINK REF="STD-DonTigny-1962" TYPE="STUDY">DonTigny 1962</LINK>: no participants with RA; 6) <LINK REF="STD-Feibel-1976" TYPE="STUDY">Feibel 1976</LINK>: not a clinical trial; 7) <LINK REF="STD-Haines-1970" TYPE="STUDY">Haines 1970</LINK>: no RA patients; 8) <LINK REF="STD-Halliday-Pegg-1969" TYPE="STUDY">Halliday Pegg 1969</LINK>: no control group; 9) <LINK REF="STD-Harris-1955" TYPE="STUDY">Harris 1955</LINK>: No description of the statistical procedure used, no p values or standard deviations available; 10) <LINK REF="STD-Hoyrup-1986" TYPE="STUDY">Hoyrup 1986</LINK>: sample of participants with trauma; 11) <LINK REF="STD-Mainardi-1979" TYPE="STUDY">Mainardi 1979</LINK>: no control group, patients were their own controls; 12) <LINK REF="STD-Oosterveld-1992c" TYPE="STUDY">Oosterveld 1992c</LINK>: sample of healthy people; 13) <LINK REF="STD-Oosterveld-1994" TYPE="STUDY">Oosterveld 1994</LINK>a): sample of healthy people; 14) <LINK REF="STD-Oosterveld-1994b" TYPE="STUDY">Oosterveld 1994b</LINK>: mixed population with RA in minority; 15) <LINK REF="STD-Weinberger-1989" TYPE="STUDY">Weinberger 1989</LINK>: no clinical outcome; 16) <LINK REF="STD-Whipple-1992" TYPE="STUDY">Whipple 1992</LINK>: sample of healthy people.</P>
<P>Two RCTs examined the effects of ice therapy versus control for the reduction of oedema and inflammation (<LINK REF="STD-Bulstrode-1986" TYPE="STUDY">Bulstrode 1986</LINK>, <LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>). One RCT compared the combination of parafin bath and exercise, to exercise only and control for pain relief on non-resisted motion, morning stiffness and joint ROM , pinch function and grip strength (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>). Another RCT compared the relative efficacy of three different thermotherapy modalities: paraffin wax bath, faradic bath and ultrasound for their effects on hand strength, ROM, joint circumference and functional status (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>). One RCT investigated the effect of different temperatures of heat on medication intake (<LINK REF="STD-Ivey-1994" TYPE="STUDY">Ivey 1994</LINK>). One RCT compared heat versus cryotherapy for the pain relief in patients with RA (<LINK REF="STD-Kirk-1968" TYPE="STUDY">Kirk 1968</LINK>). Lastly, another RCT compared heat therapy to cryotherapy for pain relief and ROM (<LINK REF="STD-Williams-1986" TYPE="STUDY">Williams 1986</LINK>).</P>
<P>Strengthening exercises (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>, <LINK REF="STD-Williams-1986" TYPE="STUDY">Williams 1986</LINK>), ultrasound (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>) or medication (<LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>) was prescribed concurrently in combination with various applications of thermotherapy.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>Methodological quality was assessed using a validated checklist (<LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>). The components of quality focus on randomization, double-blinding and description of withdrawals. Two independent reviewers (LB, VR) assessed quality and differences were resolved by consensus with a third reviewer (BS). Quality was used in subgroup analyses to test the hypothesis that poorly conducted trials demonstrate greater efficacy of the intervention under evaluation. Each item (i.e. randomization, blinding and withdrawals) was examined separately for its effect.</P>
<P>The mean methodological quality of the seven RCTs was two, with a range from one to three. Only one trial scored full points for randomization, none scored full points for double blinding, and five did not report withdrawals and dropouts. None of the included studies were double-blind.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>The results of this systematic review on thermotherapy in the treatment of RA found that there was no significant effect of hot or ice pack applications (<LINK REF="STD-Bulstrode-1986" TYPE="STUDY">Bulstrode 1986</LINK>, <LINK REF="STD-Ivey-1994" TYPE="STUDY">Ivey 1994</LINK>, <LINK REF="STD-Kirk-1968" TYPE="STUDY">Kirk 1968</LINK>, <LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>, <LINK REF="STD-Williams-1986" TYPE="STUDY">Williams 1986</LINK>) or faradic baths (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>) on objective measures of disease activity including joint swelling, pain, medication intake, ROM, grip strength or hand function when compared to a control (no active treatment) or alternate treatment. </P>
<P>There was an exception with the case of faradic baths when compared to control. For one outcome, an invalidated checklist of ability to perform daily activities, the results were conflicting since we observed significant borderline values favouring faradic baths at two weeks (0.30, 95%CI: 0.02 to 0.58) then favouring control group at three weeks (-1.30, 95%CI: -2.51 to -0.09) (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>). There was also a tendency favouring cryotherapy versus no active treatment in the reduction of hand swelling after two days (-5.80 % from baseline, 95%CI: -11.78 to 0.18) and three days (-9.80 % from baseline, 95%CI: -19.91 to -0.31) post-surgery of the hand (<LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>).</P>
<P>One trial of paraffin wax alone or combined with exercise (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>) did not report sufficient detail to analyze the results using review manager: standard deviation was not reported. However, this trial reported statistically significant results for some outcomes: the wax + exercise group showed significantly greater improvement than the control group for flexion deficit (21% relative to control), pain on non-resisted motion (44% relative to control), grip function (8% relative to control) and pinch function (5% relative to control) of the hand (p&lt;.05). There was no significant effect of wax+exercise on stiffness or grip strength. This trial found no significant improvement from baseline with paraffin wax only versus control for any outcomes (pinch and grip function, pain, stiffness and range of motion deficits).</P>
<P>There was no statistically significant difference when comparing wax and therapeutic ultrasound or wax and faradic bath to ultrasound for outcomes measured after one, two or three week(s) of treatment (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>). In addition, there was no patient preference for the various thermotherapy modalities offered (<LINK REF="STD-Kirk-1968" TYPE="STUDY">Kirk 1968</LINK>).</P>
<P>No subgroup analysis on high versus low quality applications were undertaken as none of the studies examined the same type of thermotherapy, used similar outcomes or studied the same joints. Due to the small number of trials, the remaining pre-planned subgroup analyses (treatment duration, type of thermotherapy application, patient characteristics, disease characteristics, specific joint and design considerations) were not conducted. Publication bias was not assessed due to the small number of trials.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Statistically significant results favouring paraffin wax combined with exercise to a control group were found in patients with RA of the hand after four weeks of treatment. Improvements were reported in objective measures of ROM in fingers flexion, pinch function, grip strength. These improvements ranged from 5 to 44% relative to the control group (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>).</P>
<P>No significant effect of hot pack or ice pack applications (<LINK REF="STD-Ivey-1994" TYPE="STUDY">Ivey 1994</LINK>), cryotherapy (<LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>) and faradic baths (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>) were reported for objective measures of disease activity including joint swelling, pain, medication intake, range of motion (ROM), grip strength, hand function when compared to a control group (no active treatment) or alternate therapy. No significant differences were detected between wax and therapeutic ultrasound or between wax and faradic bath combined to ultrasound for all the outcomes measured after one, two or three week(s) of treatment. There was no statistically significant difference in patient preference for any type of thermotherapy (<LINK REF="STD-Kirk-1968" TYPE="STUDY">Kirk 1968</LINK>). These interventions can be used by the patient interchangeably. </P>
<P>Physiological studies have shown significant effects of cryotherapy on circulatory and temperature responses, muscle spasm and inflammation (<LINK REF="REF-Chapman-1991" TYPE="REFERENCE">Chapman 1991</LINK>, <LINK REF="REF-Knight-1995" TYPE="REFERENCE">Knight 1995</LINK>), however, the mechanism of action is not yet fully understood (<LINK REF="REF-Knight-1995" TYPE="REFERENCE">Knight 1995</LINK>). Despite these identified physiologic effects, there appears to be no effect in human patients on objective measures of disease activity in controlled trials. Perhaps, the clinical outcome measures used in the included studies are not sensitive enough to capture the expected physiological effects.</P>
<P>Recent guidelines by the Philadelphia Panel (Philadelphia Panel 2001) did not include rheumatoid arthritis. Another systematic review (<LINK REF="REF-Puett-1994" TYPE="REFERENCE">Puett 1994</LINK>) for OA of the knee was unable to draw conclusions regarding thermotherapy, due to a lack of evidence. The American College of Rheumatology (ACR) (<LINK REF="REF-ACR-1996" TYPE="REFERENCE">ACR 1996</LINK>), The British Medical Journal (BMJ) (<LINK REF="REF-BMJ-1999" TYPE="REFERENCE">BMJ 1999</LINK>) and the Manal &amp; Snyder-Mackler (<LINK REF="REF-Manal-1996" TYPE="REFERENCE">Manal 1996</LINK>) guidelines do not make recommendations regarding thermotherapy for RA.</P>
<P>Confounding variables, such as characteristics of the therapeutic application, characteristics of the population, characteristics of the disease and methodological considerations may have contributed to the lack of effect of thermotherapy (<LINK REF="REF-Morin-1996" TYPE="REFERENCE">Morin 1996</LINK>) in the studies reviewed. Some of the characteristics of the thermotherapy application that can affect efficacy are: type of thermotherapy, temperature of the application, duration of the application (<LINK REF="REF-Behnke-1973" TYPE="REFERENCE">Behnke 1973</LINK>) and schedule of treatment (e.g. only four consecutive treatment sessions). Population characteristics of importance are: age, gender, disease duration (acute or chronic) and post-surgery. It is crucial that details on these previously mentioned characteristics should be addressed in studies of thermotherapy and need to be reported consistently in published studies.</P>
<P>Methodological considerations that may have contributed to the lack of effect are the randomization method, quality of double-blinding, sample size, study duration and selection of outcome measures. A good number of seven RCTs were retrieved from the literature. However, the low quality of the included RCTs may have caused an overestimation of effect. In particular, patients could not be blinded to thermotherapy. This is a common problem in trials of rehabilitation interventions (<LINK REF="REF-Deyo-1990" TYPE="REFERENCE">Deyo 1990</LINK>). There are also issues in including crossover design (<LINK REF="STD-Kirk-1968" TYPE="STUDY">Kirk 1968</LINK>) into systematic reviews (<LINK REF="REF-Altman-2001" TYPE="REFERENCE">Altman 2001</LINK>). Some outcome measures used in studies included in this review such as activity score (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>) or not recognized by OMERACT (OMERACT, 1993) such as stiffness (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>). Standardized outcomes measures (<LINK REF="REF-OMERACT-1993" TYPE="REFERENCE">OMERACT 1993</LINK>) and measurement periods should be used to facilitate the pooling of data of several studies.</P>
<P>Reporting data should also be standardized among the included RCTs. Mean and standard deviation of every outcome should be provided systematically. The use of statistical approximation derived from the p-value to estimate the standard deviation and the borderline significant values of the upper and lower limits of the confidence interval could affect the conclusion on efficacy of wax therapy (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>), cryotherapy (<LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>) and faradic bath (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>). Furthermore, some significant borderline results were also contradictory for the activity score at two different measurement periods (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>). Indeed, the results favoured the treatment group at two weeks and then the control group one week later (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>). Some studies expressed their results using the difference between baseline values and end of treatment values (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>). We had to recalculate the difference between groups at end of treatment. </P>
<P>Another confounding variable was concurrent therapy, such as combined exercises (<LINK REF="STD-Dellhag-1992" TYPE="STUDY">Dellhag 1992</LINK>, <LINK REF="STD-Williams-1986" TYPE="STUDY">Williams 1986</LINK>), ultrasound (<LINK REF="STD-Hawkes-1986" TYPE="STUDY">Hawkes 1986</LINK>) or medication (<LINK REF="STD-Rembe-1970" TYPE="STUDY">Rembe 1970</LINK>). These could have influenced the efficacy of the thermotherapy. Even though it reflects common clinical practice in physiotherapy, these combined interventions introduce biases and the specific efficacy of an intervention for RA cannot be isolated. For example, endorphin and enkephalin production is stimulated by exercises (<LINK REF="REF-Coutts-1994" TYPE="REFERENCE">Coutts 1994</LINK>) and may reduce arthritic pain in a combined thermotherapy modality. Combined thermotherapy modality, such as wax, may enhance the action of exercises in the treatment of RA for certain outcomes such as ROM and pain during non-resisted movement.</P>
<P>The reviewers conclude that thermotherapy, especially wax baths, can be used as a palliative therapy and an adjunct therapy combined with exercises for the treatment of RA patients arthritic hands. </P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>This review has shown neither positive nor detrimental effects of heat therapy on important outcomes or on joint destruction in RA patients. The reviewers conclude that thermotherapy can be used as needed by patients with RA, as a palliative therapy and an adjunct therapy combined with exercises. However, these conclusions are limited by the poor methodological quality of the trials available and the large number of borderline values. This review has shown that thermotherapy can be used as an adjunct and palliative therapy. No harmful side effects were reported. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>More sensitive and valid clinical outcomes should be used in studies on thermotherapy to reflect the physiological effects found in the scientific literature. Detailed information regarding the temperature, duration of application and mode of application is needed in order to determine the optimal characteristics of the therapeutic application of thermotherapy for RA at different human joints.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>The authors thank Sarah Milne, Michael Saginur, Jessie McGowan, Shannon Rees, Guillaume Léonard, Marie-Andrée Ouimet, and Catherine Lamothe for their work on this project and comments in earlier drafts.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>VR was responsible for writing the manuscript, extracting and analyzing data and selecting trials of the initial review.</P>
<P>LB contributed data extraction, update of the selection of the reference list, update of the analyses and update of the interpretation of results.</P>
<P>MJ developed the search strategy.</P>
<P>BS, GW and PT contributed methodological expertise and commented on early drafts.</P>
<P>MJ provided feedback and editorial support for final drafts.</P>
<P>LC contributed data extraction and update of the analyses.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-09 20:34:24 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-11-09 20:30:26 -0500" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-11-09 19:56:27 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bulstrode-1986" NAME="Bulstrode 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bulstrode S, Clarke A, Harrison R</AU>
<TI>A controlled trial to study the effects of ice therapy on joint inflammation in chronic arthritis</TI>
<SO>Physiotherapy Practice</SO>
<YR>1986</YR>
<VL>2</VL>
<PG>104-108</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dellhag-1992" MODIFIED="2008-11-09 19:56:27 -0500" MODIFIED_BY="[Empty name]" NAME="Dellhag 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-11-09 19:56:27 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dellhag B, Wollersjö I, Bjelle A</AU>
<TI>Effect of active hand exercise and was bath treatment in rheumatoid arthritis patients</TI>
<SO>Arthritis Care and Research</SO>
<YR>1992</YR>
<VL>5</VL>
<NO>2</NO>
<PG>87-92</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="3-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hawkes-1986" NAME="Hawkes 1986" YEAR="86">
<REFERENCE NOTES="&lt;p&gt;Hawkes J, Care G, Dixon JS, Bird HA, Wright VA. Comparison of three different treatments for rheumatoid arthritis of the hands. Physiotherapy Practice 2: 155-160, 1986.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hawkes J, Care G, Dixon JS, Bird HA, Wright VA</AU>
<TI>Comparison of three different treatments for rheumatoid arthritis of the hands</TI>
<SO>Physiotherapy Practice</SO>
<YR>1986</YR>
<VL>2</VL>
<PG>155-160</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="21-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ivey-1994" NAME="Ivey 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ivey M, Johnston RV, Ulchida T</AU>
<TI>Cryotherapy for postoperative pain relief following knee arthroplasty</TI>
<SO>The Journal of Arthroplasty</SO>
<YR>1994</YR>
<VL>9</VL>
<NO>3</NO>
<PG>285-290</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="20-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirk-1968" NAME="Kirk 1968" YEAR="1968">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirk JA, Kersley GD</AU>
<TI>Heat and Cold in the Physical Treatment of Rheumatoid Arthritis of the Knee. A Controlled Clinical Trial</TI>
<SO>Annals of Physical Medicine</SO>
<YR>1968</YR>
<VL>9</VL>
<NO>7</NO>
<PG>270-274</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rembe-1970" NAME="Rembe 1970" YEAR="1970">
<REFERENCE NOTES="&lt;p&gt;Rembe EC. Use of Cryotherapy on the Postsurgical Rheumatoid Hand. Physical Therapy 50: 19-21, 1970. 25-TH&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rembe EC</AU>
<TI>Use of Cryotherapy on the Postsurgical Rheumatoid Hand</TI>
<SO>Physical Therapy</SO>
<YR>1970</YR>
<VL>50</VL>
<PG>19-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-1986" NAME="Williams 1986" YEAR="1986">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Williams J, Harvey J, Tannenbaum H</AU>
<TI>Use of superficial heat versus ice for the rheumatoid arthrtis shoulder: A pilot study</TI>
<SO>Physiotherapy Canada</SO>
<YR>1986</YR>
<VL>38</VL>
<NO>1</NO>
<PG>8-13</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="19-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-11-09 20:30:26 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abramson-1964" NAME="Abramson 1964" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Abramson DI, Tuck S, Chu LSW, Augustin C. Effect of paraffin bath and hot fomentations on local tissue temperatures. Archives of Physical Medicine and Rehabilitation 45: 87-94, 1964.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abramson DI, Tuck S, Chu LSW, Augustin C</AU>
<TI>Effect of paraffin bath and hot fomentations on local tissue temperatures</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1964</YR>
<VL>45</VL>
<PG>87-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amundson-1979" NAME="Amundson 1979" YEAR="1979">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Amundson H</AU>
<TI>Thermography and cryotherapy : effects on joint degeneration in rheumatoid arthritis</TI>
<SO>Physiotherapy Canada</SO>
<YR>1979</YR>
<VL>31</VL>
<PG>258-262</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="22-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bromley-1994" NAME="Bromley 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bromley J, Unsworth A, Haslock I</AU>
<TI>Changes in Stiffness Following Short- and Long-term Application of Standard Physiotherapeutic Techniques</TI>
<SO>British Journal of Rheumatology</SO>
<YR>1994</YR>
<VL>33</VL>
<PG>555-561</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="16-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Curkovic-1993" NAME="Curkovic 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Curkovic B. The influence of heat and colde on pain... Zeitschrift fur Rheumatologie 1993; 52(5): 289-91.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Curkovic B, Vitulic V, Babic-Naglic D, Durrigl T</AU>
<TI>The influence of heat and colde on pain arthritis</TI>
<SO>Zeitschrift fur Rheumatologie</SO>
<YR>1993</YR>
<VL>52</VL>
<NO>5</NO>
<PG>289-91</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="2-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Devereaux-1985" NAME="Devereaux 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Devereaux MD, Parr GR, Page Thomas DP, Hazleman BL</AU>
<TI>Disease activity indexes in rheumatoid arthritis; a prospective, comparative study with thermography</TI>
<SO>Annals of the Rheumatic Diseases</SO>
<YR>1985</YR>
<VL>44</VL>
<PG>434-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DonTigny-1962" NAME="DonTigny 1962" YEAR="1962">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>DonTigny R, Sheldon K</AU>
<TI>Simultaneous use of heat and cold in treatment of muscle spasm</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1962</YR>
<VL>43</VL>
<PG>235-237</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feibel-1976" MODIFIED="2008-11-09 20:30:26 -0500" MODIFIED_BY="[Empty name]" NAME="Feibel 1976" YEAR="1976">
<REFERENCE MODIFIED="2008-11-09 20:30:26 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Feibel A, Fast A</AU>
<TI>Deep heating of joints : a reconsideration</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1976</YR>
<VL>57</VL>
<NO>11</NO>
<PG>513-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haines-1970" NAME="Haines 1970" YEAR="1970">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Haines J</AU>
<TI>A study into a report on cold therapy</TI>
<SO>Physiotherapy</SO>
<YR>1970</YR>
<VL>56</VL>
<NO>11</NO>
<PG>501-502</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="23-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Halliday-Pegg-1969" NAME="Halliday Pegg 1969" YEAR="1969">
<REFERENCE NOTES="&lt;p&gt;Halliday Pegg SM, Littler TR, Littler EN. A trial of ice therapy and exercise in chronic arthritis. Physiotherapy 1969; 55: 51-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halliday Pegg SM, Littler TR, Littler EN</AU>
<TI>A trial of ice therapy and exercise in chronic arthritis</TI>
<SO>Physiotherapy</SO>
<YR>1969</YR>
<VL>55</VL>
<PG>51-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="9-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harris-1955" NAME="Harris 1955" YEAR="1955">
<REFERENCE NOTES="&lt;p&gt;Harris R &amp;amp; Millard JB. Paraffin wax baths in the treatment of Rheumatoid Arthritis. Ann Rheum 14: 278-282, 1955.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harris R &amp; Millard JB</AU>
<TI>Paraffin wax baths in the treatment of Rheumatoid Arthritis.</TI>
<SO>Ann Rheum</SO>
<YR>1955</YR>
<VL>14</VL>
<PG>278-282</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoyrup-1986" NAME="Hoyrup 1986" YEAR="1986">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hoyrup G, Kjorvel L</AU>
<TI>Comparison of whirpool and wax treatments for hand therapy</TI>
<SO>Physiotherapy Canada</SO>
<YR>1986</YR>
<VL>38</VL>
<PG>79-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mainardi-1979" NAME="Mainardi 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mainardi CL, Walter JM, Spiegel PK, Goldkamp OG, Harris ED</AU>
<TI>Rheumatoid Arthritis: Failure of Daily Heat Therapy to Affect its Progression</TI>
<SO>Arch Phys Med Rehabil</SO>
<YR>1979</YR>
<VL>60</VL>
<PG>390-393</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oosterveld-1992c" NAME="Oosterveld 1992c" YEAR="1992">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Oosterveld FGJ, Rasker JJ, Jacobs JW, Overmars HJ</AU>
<TI>The effect of local heat and cold therapy on the intraarticular and skin surface temperature of the knee</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1992</YR>
<VL>35</VL>
<NO>2</NO>
<PG>146-151</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="17-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oosterveld-1994" NAME="Oosterveld 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Oosterveld FGJ, Rasker JJ</AU>
<TI>Effects of local heat and cold treatment on surface and articular temperature of arthritic knees</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1994</YR>
<VL>37</VL>
<NO>11</NO>
<PG>1578-1582</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="18-TH"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oosterveld-1994b" NAME="Oosterveld 1994b" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Oosterveld FGJ, Rasker JJ</AU>
<TI>Treating arthritis with locally applied heat or cold</TI>
<SO>Seminars in Arthritis and Rheumatism</SO>
<YR>1994</YR>
<VL>24</VL>
<NO>2</NO>
<PG>82-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinberger-1989" NAME="Weinberger 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weinberger, Fadilah R, Lev A, Pinkhas J</AU>
<TI>Intra-articular temperature measurements after superficial heating</TI>
<SO>Scandinavian Journal of Rehabilitation Medicine</SO>
<YR>1989</YR>
<VL>21</VL>
<NO>1</NO>
<PG>55-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whipple-1992" NAME="Whipple 1992" YEAR="1992">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Whipple-Ellsworth A, Klebba M, Walden J, Kulig K</AU>
<TI>A comparison of the analgesic effects of ice massage and brief intense transcutaneous electrical nerve stimulation</TI>
<SO>Physical Therapy</SO>
<YR>1992</YR>
<VL>72</VL>
<NO>6</NO>
<PG>S69</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-09 20:34:24 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-09 20:32:40 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-ACR-1996" MODIFIED="2008-11-09 20:31:24 -0500" MODIFIED_BY="[Empty name]" NAME="ACR 1996" TYPE="JOURNAL_ARTICLE">
<AU>American College of Rheumatology Ad Hoc Committee on Clinical Guidelines</AU>
<TI>Guidelines for the management of rheumatoid arthritis</TI>
<SO>Arthritis &amp; Rheumatism</SO>
<YR>1996</YR>
<VL>39</VL>
<PG>713-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Altman-2001" MODIFIED="2008-11-09 20:31:30 -0500" MODIFIED_BY="[Empty name]" NAME="Altman 2001" TYPE="CONFERENCE_PROC">
<AU>Altman D, Elbourne D</AU>
<SO>Incorporating crossover trials into systematic reviews. Proceedings of the 9th International Cochrane Colloquium</SO>
<YR>2001</YR>
<PG>131</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APTA-2001" MODIFIED="2008-11-09 20:31:35 -0500" MODIFIED_BY="[Empty name]" NAME="APTA 2001" TYPE="BOOK">
<AU>American Physical Therapy Association</AU>
<SO>Guide to Physical Therapist Practice: Part One: A Description of Patient/Client Management</SO>
<YR>2001</YR>
<PB>American Physical Therapy Association</PB>
<CY>Alexandria, Va</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arnett-1988" MODIFIED="2008-11-09 20:31:45 -0500" MODIFIED_BY="[Empty name]" NAME="Arnett 1988" TYPE="JOURNAL_ARTICLE">
<AU>Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neudstadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG</AU>
<TI>The American Rheumatism Association 1987 Revised Criteria for Classification of Rheumatoid Arthritis</TI>
<SO>Arthritis Rheumatology</SO>
<YR>1988</YR>
<VL>31</VL>
<PG>315-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Behnke-1973" MODIFIED="2008-11-09 20:31:50 -0500" MODIFIED_BY="[Empty name]" NAME="Behnke 1973" TYPE="JOURNAL_ARTICLE">
<AU>Behnke RS</AU>
<TI>Cryotherapy and vasodilatation</TI>
<SO>Athl Train</SO>
<YR>1973</YR>
<VL>8</VL>
<NO>106</NO>
<PG>133-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-BMJ-1999" MODIFIED="2008-11-09 20:31:55 -0500" MODIFIED_BY="[Empty name]" NAME="BMJ 1999" TYPE="BOOK">
<AU>BMJ</AU>
<SO>British Medicine Journal Clinical Evidence. A Compendium of the Best Available Evidence for Effective Health Care</SO>
<YR>1999</YR>
<PB>British Medical Journal</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chapman-1991" MODIFIED="2008-11-09 20:18:00 -0500" MODIFIED_BY="[Empty name]" NAME="Chapman 1991" TYPE="JOURNAL_ARTICLE">
<AU>Chapman CE</AU>
<TI>Can the use of physical modalities for pain control be rationalized by the research evidence?</TI>
<SO>Canadian Journal of Physiology and Pharmacology</SO>
<YR>1991</YR>
<VL>69</VL>
<PG>704-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coutts-1994" MODIFIED="2008-11-09 20:32:00 -0500" MODIFIED_BY="[Empty name]" NAME="Coutts 1994" TYPE="BOOK_SECTION">
<AU>Coutts RD, Toth C, Kaita JH</AU>
<TI>The role of continuous passive motion in the rehabilitation of the total knee patient</TI>
<SO>Total Knee Arthroplasty: A Comprehensive Approach</SO>
<YR>1994</YR>
<PG>126-32</PG>
<ED>Hungerford DS, Krackow K, Kenne RV</ED>
<PB>Williams and Wilkins</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deyo-1990" MODIFIED="2008-11-09 20:19:14 -0500" MODIFIED_BY="[Empty name]" NAME="Deyo 1990" TYPE="JOURNAL_ARTICLE">
<AU>Deyo RA, Walsh NE, Schoenfeld LS, Ramamurty S</AU>
<TI>Can trials of physical treatments be blinded: the example of transcutaneous electrical nerve stimulation for chronic pain</TI>
<SO>American Journal of Physical Medicine and Rehabilitation</SO>
<YR>1990</YR>
<VL>69</VL>
<PG>6-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" MODIFIED="2008-11-09 20:19:27 -0500" MODIFIED_BY="[Empty name]" NAME="Dickersin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Lefebvre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<NO>6964</NO>
<PG>1286-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haynes-1994" MODIFIED="2008-11-09 20:22:20 -0500" MODIFIED_BY="[Empty name]" NAME="Haynes 1994" TYPE="JOURNAL_ARTICLE">
<AU>Haynes R, Wilczynski N, McKibbon KA et al</AU>
<TI>Developing optimal search strategies for detecting clinically sound strategies in MEDLINE</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>1994</YR>
<VL>1</VL>
<PG>447-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad A, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al.</AU>
<TI>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Knight-1995" NAME="Knight 1995" TYPE="BOOK">
<AU>Knight KL</AU>
<SO>Cryotherapy for sport injuries management</SO>
<YR>1995</YR>
<PB>Human Kinetics</PB>
<CY>Windsor, Canada</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manal-1996" MODIFIED="2008-11-09 20:32:13 -0500" MODIFIED_BY="[Empty name]" NAME="Manal 1996" TYPE="JOURNAL_ARTICLE">
<AU>Manal R.J. Snyder-Mackler, L.</AU>
<TI>Practice guidelines for anterior cruciate ligament rehabilitation: criterion-based rehabilitation progression.</TI>
<SO>Operative techniques in Orthopaedics</SO>
<YR>1996</YR>
<VL>6</VL>
<PG>190-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morin-1996" MODIFIED="2008-11-09 20:32:19 -0500" MODIFIED_BY="[Empty name]" NAME="Morin 1996" TYPE="CONFERENCE_PROC">
<AU>Morin M, Brosseau L, Quirion-DeGrardi C</AU>
<SO>A theoretical framework on low level laser therapy (classes I, II and III) application for the treatment of OA and RA. Proceedings of the Canadian Physiotherapy Association National Congress, Victoria (B.C.)</SO>
<YR>1996</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mulrow-1997" MODIFIED="2008-11-09 20:32:24 -0500" MODIFIED_BY="[Empty name]" NAME="Mulrow 1997" TYPE="OTHER">
<TI>Mulrow CD, Oxman AD (eds). Cochrane Collaboration Handbook [updated September 1997]</TI>
<SO>In: The Cochrane Library. The Cochrane Collaboration</SO>
<PG>Update Software; 1994, issue 4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-OMERACT-1993" MODIFIED="2008-11-09 19:59:48 -0500" MODIFIED_BY="[Empty name]" NAME="OMERACT 1993" TYPE="JOURNAL_ARTICLE">
<AU>OMERACT</AU>
<TI>Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials</TI>
<SO>Journal of Rheumatology</SO>
<YR>1993</YR>
<VL>20</VL>
<PG>526-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Philadelphia-2001" MODIFIED="2008-11-09 20:32:30 -0500" MODIFIED_BY="[Empty name]" NAME="Philadelphia 2001" TYPE="JOURNAL_ARTICLE">
<AU>The Philadelphia Panel</AU>
<TI>The Philadelphia Panel Evidence-Based Clinical Practice Guidelines on Selected Rehabilitation Interventions</TI>
<SO>Physical Therapy</SO>
<YR>2001</YR>
<VL>81</VL>
<PG>1641-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Primer-1997" MODIFIED="2008-11-09 20:26:11 -0500" MODIFIED_BY="[Empty name]" NAME="Primer 1997" TYPE="BOOK">
<AU>Arthritis Foundation</AU>
<SO>Primer on the Rheumatic Diseases</SO>
<YR>1997</YR>
<EN>11</EN>
<PB>Ed Klippel, J.H</PB>
<CY>Atlanta</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Puett-1994" MODIFIED="2008-11-09 20:32:35 -0500" MODIFIED_BY="[Empty name]" NAME="Puett 1994" TYPE="JOURNAL_ARTICLE">
<AU>Puett DW, Griffin MR</AU>
<TI>Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1994</YR>
<VL>121</VL>
<PG>133-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Semble-1990" MODIFIED="2008-11-09 20:32:40 -0500" MODIFIED_BY="[Empty name]" NAME="Semble 1990" TYPE="JOURNAL_ARTICLE">
<AU>Semble EL, Loeser RF, Wise CM</AU>
<TI>Therapeutic exercise for rheumatoid arthritis and osteoarthritis</TI>
<SO>Seminars in Arthritis and Rheumatism</SO>
<YR>1990</YR>
<VL>20</VL>
<PG>32-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verhagen-2000" MODIFIED="2008-11-09 20:13:19 -0500" MODIFIED_BY="[Empty name]" NAME="Verhagen 2000" TYPE="COCHRANE_REVIEW">
<AU>Verhagen AP, de Vet HCW, de Bie RA, Kessels AGH, Boers M, Knipschild PG</AU>
<TI>Balneotherapy for rheumatoid arthritis and osteoarthritis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2008-11-09 20:13:19 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-11-09 20:13:19 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" DOI: 10.1002/14651858.CD000518 "/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2008-11-09 20:34:24 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Harris-1955" MODIFIED="2008-11-09 20:34:24 -0500" MODIFIED_BY="[Empty name]" NAME="Harris 1955" TYPE="JOURNAL_ARTICLE">
<AU>Harris R &amp; Millard JB</AU>
<TI>Paraffin wax baths in the treatment of Rheumatoid Arthritis</TI>
<SO>Annals of the Rheumatic Diseases</SO>
<YR>1955</YR>
<VL>14</VL>
<PG>278-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Philadelphia-Panel" NAME="Philadelphia Panel" TYPE="UNPUBLISHED">
<AU>Philadelphia Panel, Ottawa Methods Group</AU>
<TI>Philadelphia Panel Guidelines on rehabilitation interventions for knee pain</TI>
<SO>Physical Therapy</SO>
<YR>Submitted August 2000</YR>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Bulstrode-1986">
<CHAR_METHODS>
<P>Randomized, single-blind (assessor) controlled trial<BR/>Sample size at entry: 24</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Inpatients confined to bed rest with classical or definite RA according to ARA criteria and clinically obvious effusion of 1 or both knee joints<BR/>Men: 17<BR/>Seropositive: 19<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1-Experimental group: Ice therapy (2 kg of crushed ice wrapped in damp towels applied to one of knee joints for 10 minutes daily for 5 days)</P>
<P>2-Control group: No ice therapy</P>
<P>Contralateral control: patients with both knees affected, only one knee was assigned to ice therapy and the other served as a contralateral control</P>
<P>Concurrent therapy: no intra-articular injections, joint aspiration, no changes in drug therapy, no other forms of physical therapy</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1-Inflammation measured by infrared thermography (Thermographic Index), derived from mean temperature of anterior knee</P>
<P>2-Circumference (cm)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=0<BR/>W=1</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dellhag-1992">
<CHAR_METHODS>
<P>Randomized, Controlled with matching, parallel group, Sample size at entry for <BR/>group 1: 13<BR/>group 2: 11<BR/>group 3: 15<BR/>group 4: 13</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Resident in the city of Gothenburg, age equal or younger than 70 yrs, disease duration:6-10 yrs, functional class. I or II, hand problems defined as a decrease in the ROM and/or grip strength, Mean age for females: 51.8 yrs (n=33), Mean age for males: 56.3 yrs (n=19), Stage of disease: chronic.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: Wax bath &amp; Exercises</P>
<P>Group 2: Exercises only</P>
<P>Group 3: Wax bath only</P>
<P>Group 4: control<BR/>(no treatment)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1-ROM deficit (mm) :<BR/>- flexion of dom. hand.<BR/>- flexion of non-dom. hand.<BR/>- extension of dom. hand.<BR/>- extension of non-dom. hand.</P>
<P>2-Grip strength Test (0-80 pts)</P>
<P>3-Pinch function Test (0-32 pts)</P>
<P>4- Grip strength (N) :<BR/>- max. dom. hand.<BR/>- max. non-dom. hand.<BR/>- average of dom. hand<BR/>- average of non-dom. hand.</P>
<P>5-Pain:<BR/>- resisted motion of dom. hand (0-9 pts)<BR/>- non-resisted motion, both hands (0-100mm)</P>
<P>6-Stiffness both hands (0-100mm)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=0<BR/>W=0</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hawkes-1986">
<CHAR_METHODS>
<P>Randomized, placebo-controlled study. Sample size at entry for group 1: 10; for group 2: 10</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients with classical/definite RA disease involved in both hands, pain swelling and limitation of movement</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1- Wax + exercises;<BR/>2-Ultrasound + exercises;<BR/>2-Ultrasound + faradic exercises</P>
<P>3-Ultrasound +Faradic bath</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1- Hand grip (mmHg)<BR/>2- PIP circumference (mm)<BR/>3- Articular Index (0-3)<BR/>4- Pain score (mm)<BR/>5-ROM (mm)<BR/>6- Timed task (sec)<BR/>7- Activity score (checklist)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=0<BR/>W=0</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ivey-1994">
<CHAR_METHODS>
<P>Randomized, parallel group, Placebo controlled, Sample size at entry for <BR/>Group 1: 30<BR/>Group 2: 30<BR/>Group 3: 30</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients undergoing primary knee arthroplasty, Mean age or the following groups:<BR/>Group 1: 64.5 yrs<BR/>SD: 8.1 yrs<BR/>Group 2: 64.2 yrs<BR/>SD: 10.3 yrs<BR/>Group 3: 66.9 yrs<BR/>SD: 11.6 yrs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1-Thermal-pad of 50°F 2-Thermal-pad of 60°F<BR/>3-Thermal-pad of 70°F</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1-Amount of morphine injected (pain measurement) (mg/h)<BR/>2-No. of PCA (Patient controlled analgesia attempts)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=2<BR/>B=0<BR/>W=1</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kirk-1968">
<CHAR_METHODS>
<P>Randomized, cross-over trial<BR/>Washout: 9 days with no therapy<BR/>Sample size at entry: 14 patients, 20 knees<BR/>Treatment duration: 5 days<BR/>Trial duration: 19 days</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Chronic rheumatoid arthritis, admitted to hospital with "definite or classic" RA<BR/>Mean age: not reported<BR/>Mean symptom duration: 14 years SD=12.5</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1-Ice packs in damp towels for 20 minutes, 1/day for 5 days</P>
<P>2-Hot packs: wrapped in Turkish towel and wrapped around the knee for 20 minutes, 1/day for 5 days<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1-Preference for cold<BR/>2-Preference for heat<BR/>3-Improved by 1 pain grade (heat and ice)<BR/>4-Stiffness improved (heat and ice)</P>
<P>Pain, stiffness, range of movement, knee circumference, joint temperature, treatment preference</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=0<BR/>W=0</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Rembe-1970">
<CHAR_METHODS>
<P>Randomized, parallel group, Placebo controlled, Sample size at entry for <BR/>Group 1: 15<BR/>Group 2: 15<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Patients hospitalized for surgical procedures to the hand</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>at 10 degrees 1-cryotherapy, submerging involved hand, covered in glove in water at 10 degrees Celsius for 4 mins., 2/day, after 48 hrs post-op until 72 hours post-op.<BR/>2- no therapy<BR/>2-Hot packs: wrapped in Turkish towel and wrapped around the knee for 20 minutes, 1/day for 5 days<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1-% of increase oedema over preoperative volume</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=0<BR/>W=1</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Williams-1986">
<CHAR_METHODS>
<P>Randomized, parallel group, Sample size at entry for group 1: 9, for group 2: 9</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Onset of rheumatoid arthrtis within the proceeding 5 yrs, painful shoulder, normal sensations (hot&amp;cold), stage of disease: early &amp; advanced, Group 1 mean age: 59 yrs, Group 2 mean age: 55 yrs, Mean disease duration for group 1: 31 mths, Mean disease duration for group 2: 36 mths.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>1-Heat (hot packs) for 20 min. + 20 min.of exercise program<BR/>2-Ice (20 min.) + exercises program</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>1-Pain (McGill Pain Questionnaire)<BR/>2-Flexion (degrees)<BR/>3-Abduction ROM (degrees)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>R=1<BR/>B=0<BR/>W=0</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Abramson-1964">
<CHAR_REASON_FOR_EXCLUSION>
<P>No clinical outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Amundson-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a clinical trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bromley-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Healthy subjects</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Curkovic-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>No sufficient statistical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Devereaux-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-DonTigny-1962">
<CHAR_REASON_FOR_EXCLUSION>
<P>No subjects with rheumatoid arthritis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Feibel-1976">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a clinical trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Haines-1970">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RA patients. Survey to estimate the number of hospitals who find it worth while to use cold therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Halliday-Pegg-1969">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Harris-1955">
<CHAR_REASON_FOR_EXCLUSION>
<P>No description of the statistical procedure used, no p values and no standard deviations available</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hoyrup-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Subjects with traumas</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mainardi-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>No control group. Patient was his own control.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Oosterveld-1992c">
<CHAR_REASON_FOR_EXCLUSION>
<P>Healthy subjects</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Oosterveld-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed population with rheumatoid arthritis in minority</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Oosterveld-1994b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Literature review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Weinberger-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>No clinical outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Whipple-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Healthy subjects</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bulstrode-1986">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dellhag-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hawkes-1986">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Ivey-1994">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kirk-1968">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rembe-1970">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Williams-1986">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>50°F Thermal-pad vs 60°F Thermal-pad (knee)(End of treatment - 72 hrs)</NAME>
<CONT_OUTCOME CHI2="1.9657122154134606E-32" CI_END="0.5880059283685084" CI_START="-0.18800592836850796" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2000000000000002" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.3123634361552431" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="28" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="1.0102752773811141">
<NAME>Pain measurement (amount of morphine injected - mg/h)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5880059283685084" CI_START="-0.188005928368508" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.4" ORDER="146975" SD_1="0.8" SD_2="0.7" SE="0.19796584602015618" STUDY_ID="STD-Ivey-1994" TOTAL_1="28" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.5394566793572184" CI_START="-1.139456679357218" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.7697892355402699" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="28" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.2926505970287308">
<NAME># of attempts per hour as monitored by a PCA machine (patient controlled analgesia machine)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.5394566793572184" CI_START="-1.139456679357218" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.4" ORDER="146976" SD_1="2.4" SD_2="2.8" SE="0.6834088227756641" STUDY_ID="STD-Ivey-1994" TOTAL_1="28" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>50°F Thermal-pad vs 70°F Thermal-pad (knee)(End of treatment - 72 hrs)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.0938007761542439" CI_START="-1.6938007761542435" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6731269996217929" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="28" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.42186028693741134">
<NAME>Pain measurement (amount of morphine injected - mg/h)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0938007761542439" CI_START="-1.6938007761542435" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.9" ORDER="146977" SD_1="2.4" SD_2="3.0" SE="0.7111359122659224" STUDY_ID="STD-Ivey-1994" TOTAL_1="28" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.6659266031498212" CI_START="-0.06592660314982113" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.10808725705733961" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="28" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="1.606850090429955">
<NAME># of attempts per hour as monitored by a PCA machine (patient controlled analgesia machine)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.6659266031498212" CI_START="-0.06592660314982113" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.3" ORDER="146978" SD_1="0.8" SD_2="0.6" SE="0.1867006771737662" STUDY_ID="STD-Ivey-1994" TOTAL_1="28" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>60°F Thermal-pad vs 70°F Thermal-pad (knee)(End of treatment - 72 hrs)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.4299110990145681" CI_START="-0.22991109901456835" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5524529079564819" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.5940885257860038">
<NAME>Pain measurement (amount of morphine injected - mg/h)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4299110990145681" CI_START="-0.22991109901456835" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.3" ORDER="146979" SD_1="0.7" SD_2="0.6" SE="0.16832508230603463" STUDY_ID="STD-Ivey-1994" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.9684477807136926" CI_START="-1.9684477807136926" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.5045427873518087" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.6673591019993492">
<NAME># of attempts per hour as monitored by a PCA machine (patient controlled analgesia machine)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9684477807136926" CI_START="-1.9684477807136926" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="3.9" ORDER="146980" SD_1="2.8" SD_2="3.0" SE="0.7492218185112692" STUDY_ID="STD-Ivey-1994" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Ice packs vs Control (knee)(End of therapy - 5 days)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.1146033346532922" CI_START="-1.3146033346532933" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6000000000000005" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.09983831408201568" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" UNITS="" WEIGHT="100.0" Z="1.645637983615887">
<NAME>Thermographic Index (derived from mean temperature, a decrease is good))</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.1146033346532922" CI_START="-1.3146033346532933" EFFECT_SIZE="-0.6000000000000005" ESTIMABLE="YES" MEAN_1="4.6" MEAN_2="5.2" ORDER="146981" SD_1="1.12" SD_2="0.86" SE="0.3646002377033418" STUDY_ID="STD-Bulstrode-1986" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.85667297940519" CI_START="-1.4566729794051843" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.7000000000000028" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.52467646465545" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" UNITS="" WEIGHT="100.0" Z="0.6361533724767283">
<NAME>Joint circumference (cm)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.85667297940519" CI_START="-1.4566729794051843" EFFECT_SIZE="0.7000000000000028" ESTIMABLE="YES" MEAN_1="39.6" MEAN_2="38.9" ORDER="146982" SD_1="2.46" SD_2="3.48" SE="1.1003635762783135" STUDY_ID="STD-Bulstrode-1986" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Ice packs vs Hot packs (knee)(End of treatment - 5 days)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.632939207890691" CI_START="0.40354269371539087" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.7550546569602985" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.8826918034817212" LOG_CI_START="-0.39411051134056285" LOG_EFFECT_SIZE="0.24429064607057913" METHOD="PETO" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.4532547107612446" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="14" WEIGHT="100.0" Z="0.75">
<NAME># of patients prefering ice</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.632939207890691" CI_START="0.40354269371539087" EFFECT_SIZE="1.7550546569602985" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.8826918034817212" LOG_CI_START="-0.39411051134056285" LOG_EFFECT_SIZE="0.24429064607057913" ORDER="146983" O_E="1.0" SE="0.75" STUDY_ID="STD-Kirk-1968" TOTAL_1="14" TOTAL_2="14" VAR="1.7777777777777777" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.672016808737407" CI_START="0.3067572383280919" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.3190649006014845" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="0.7537375091868379" LOG_CI_START="-0.5132051807481138" LOG_EFFECT_SIZE="0.12026616421936208" METHOD="PETO" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.7098152673500423" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="14" WEIGHT="100.0" Z="0.3721042037676254">
<NAME># of patients with improved pain grading</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.672016808737407" CI_START="0.3067572383280919" EFFECT_SIZE="1.3190649006014845" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.7537375091868379" LOG_CI_START="-0.5132051807481138" LOG_EFFECT_SIZE="0.12026616421936208" ORDER="146984" O_E="0.5" SE="0.7442084075352507" STUDY_ID="STD-Kirk-1968" TOTAL_1="14" TOTAL_2="14" VAR="1.8055555555555554" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="19.303274202987108" CI_START="0.7708397844014595" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="3.8574255306969745" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="1.2856309798723675" LOG_CI_START="-0.11303587873358749" LOG_EFFECT_SIZE="0.58629755056939" METHOD="PETO" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.10034824645925969" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="14" WEIGHT="100.0" Z="1.6431676725154987">
<NAME># of patients with improved stiffness grading</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="19.30327420298712" CI_START="0.7708397844014593" EFFECT_SIZE="3.8574255306969745" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.2856309798723677" LOG_CI_START="-0.11303587873358761" LOG_EFFECT_SIZE="0.58629755056939" ORDER="146985" O_E="2.0" SE="0.8215838362577492" STUDY_ID="STD-Kirk-1968" TOTAL_1="14" TOTAL_2="14" VAR="1.4814814814814814" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Hot packs vs Ice packs (shoulder)(End of treatment - 3 wks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.186529268751104" CI_START="-7.586529268751105" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.2000000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.7126731288883263" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="100.0" Z="0.3682683790327315">
<NAME>Pain (McGill Pain Questionnaire)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.186529268751104" CI_START="-7.586529268751105" EFFECT_SIZE="-1.2000000000000002" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="6.9" ORDER="146986" SD_1="8.4" SD_2="5.0" SE="3.258493175959983" STUDY_ID="STD-Williams-1986" TOTAL_1="9" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="29.716755355298595" CI_START="-15.316755355298596" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="7.199999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.530841637017687" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="100.0" Z="0.62672176634755">
<NAME>Flexion (degrees)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="29.716755355298595" CI_START="-15.316755355298596" EFFECT_SIZE="7.199999999999999" ESTIMABLE="YES" MEAN_1="12.2" MEAN_2="5.0" ORDER="146987" SD_1="12.8" SD_2="32.0" SE="11.48835158855361" STUDY_ID="STD-Williams-1986" TOTAL_1="9" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.698579513399686E-34" CI_END="31.248869561223007" CI_START="-24.648869561223005" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.300000000000001" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-006.03" NO="3" P_CHI2="0.0" P_Q="1.0" P_Z="0.8169898145753464" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="9" TOTAL_2="9" UNITS="" WEIGHT="100.0" Z="0.23141834537579611">
<NAME>Abduction ROM (degrees)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="31.248869561223007" CI_START="-24.648869561223005" EFFECT_SIZE="3.3000000000000007" ESTIMABLE="YES" MEAN_1="26.1" MEAN_2="22.8" ORDER="146988" SD_1="21.3" SD_2="37.1" SE="14.259889355967825" STUDY_ID="STD-Williams-1986" TOTAL_1="9" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Wax bath vs Control (hand)(End of treatment - 4 wks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.837159350137032" CI_START="-37.362840649862974" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-19.1" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.040383196090913155" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.049807739246519">
<NAME>Flexion of the dominant hand (ROM deficit in mm, lower score is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.837159350137032" CI_START="-37.362840649862974" EFFECT_SIZE="-19.1" ESTIMABLE="YES" MEAN_1="42.9" MEAN_2="62.0" ORDER="146989" SD_1="24.59" SD_2="24.59" SE="9.317947061230678" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.2991227754835446" CI_START="-23.50087722451645" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.899999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.04437822552743787" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.010500668581881">
<NAME>Extension of the dominant hand (ROM deficit in mm, lower score is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.2991227754835446" CI_START="-23.50087722451645" EFFECT_SIZE="-11.899999999999999" ESTIMABLE="YES" MEAN_1="21.6" MEAN_2="33.5" ORDER="146990" SD_1="15.62" SD_2="15.62" SE="5.918923672079024" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Grip Function Test (0-80 pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="75.0" MEAN_2="75.0" ORDER="146991" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.02362131082397967" CI_START="-1.7763786891760174" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.044136567344431984" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.012791511104119">
<NAME>Pinch Function Test (0-32 pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.02362131082397967" CI_START="-1.7763786891760174" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="28.3" MEAN_2="29.2" ORDER="146992" SD_1="1.18" SD_2="1.18" SE="0.44714020057959336" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.23860825930088403" CI_START="-18.761391740699118" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-9.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.044382523228421907" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.010460023120129">
<NAME>Grip strength (N) (average of dominant hand)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.23860825930088403" CI_START="-18.761391740699118" EFFECT_SIZE="-9.5" ESTIMABLE="YES" MEAN_1="75.9" MEAN_2="85.4" ORDER="146993" SD_1="12.47" SD_2="12.47" SE="4.725286695955534" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.936524496101245E-32" CI_END="0.19655019457023948" CI_START="0.0034498054297607272" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.1000000000000001" ESTIMABLE="YES" I2="99.99999999999999" I2_Q="0.0" ID="CMP-007.06" NO="6" P_CHI2="0.0" P_Q="1.0" P_Z="0.04235706202833641" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.0299948573528774">
<NAME>Pain on resisted motion (0-9 pts, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.19655019457023948" CI_START="0.0034498054297607134" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.5" ORDER="146994" SD_1="0.13" SD_2="0.13" SE="0.04926120853842978" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.31522843333755013" CI_START="-14.084771566662456" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.040393368852310985" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.049703545288341">
<NAME>Pain, non-resisted motion with both hands (VAS: 0-100mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.31522843333755013" CI_START="-14.084771566662456" EFFECT_SIZE="-7.200000000000003" ESTIMABLE="YES" MEAN_1="25.9" MEAN_2="33.1" ORDER="146995" SD_1="9.27" SD_2="9.27" SE="3.512703101163415" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.0806860215768812" CI_START="-6.319313978423118" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.0443612155356494" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.0106615729971336">
<NAME>Stiffness, both hands (VAS: 0-100mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.0806860215768812" CI_START="-6.319313978423118" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="30.2" ORDER="146996" SD_1="4.2" SD_2="4.2" SE="1.5915159681646542" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Wax bath + exercises vs exercises (hand) (End of treatment - 4 wks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="16.160829650939476" CI_START="0.43917034906053143" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="8.300000000000004" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.038502600773189455" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.0694636309461627">
<NAME>Flexion of the dominant hand (ROM deficit in mm, lower score is better) *</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours</GRAPH_LABEL_2>
<CONT_DATA CI_END="16.160829650939476" CI_START="0.43917034906053143" EFFECT_SIZE="8.300000000000004" ESTIMABLE="YES" MEAN_1="52.1" MEAN_2="43.8" ORDER="146997" SD_1="9.79" SD_2="9.79" SE="4.010701070501649" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.021879739665331188" CI_START="-1.1781202603346717" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.041937334752710956" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.0341414605384505">
<NAME>Extension of the dominant hand (ROM deficit in mm, lower score is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.021879739665331188" CI_START="-1.1781202603346717" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" MEAN_1="32.9" MEAN_2="33.5" ORDER="146998" SD_1="0.72" SD_2="0.72" SE="0.29496473654353295" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.04740610260821154" CI_START="-2.552593897391783" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.2999999999999972" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.041937334752711906" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.034141460538441">
<NAME>Grip Function Test (0-80pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.04740610260821154" CI_START="-2.552593897391783" EFFECT_SIZE="-1.2999999999999972" ESTIMABLE="YES" MEAN_1="74.8" MEAN_2="76.1" ORDER="146999" SD_1="1.56" SD_2="1.56" SE="0.6390902625109881" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pinch Function Test (0-32 pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="29.3" MEAN_2="29.3" ORDER="147000" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-1.6175595637283848" CI_START="-92.38244043627162" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-47.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.04237456581861214" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.02982268886002">
<NAME>Grip strength (N) (average dominant hand)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.6175595637283848" CI_START="-92.38244043627162" EFFECT_SIZE="-47.0" ESTIMABLE="YES" MEAN_1="79.2" MEAN_2="126.2" ORDER="147001" SD_1="56.52" SD_2="56.52" SE="23.15473181866734" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.01823311638777486" CI_START="-0.9817668836122251" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.04193733475271139" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.034141460538446">
<NAME>Pain on resisted motion (0-9pts, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.01823311638777486" CI_START="-0.9817668836122251" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="1.3" ORDER="147002" SD_1="0.6" SD_2="0.6" SE="0.2458039471196108" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.925698284182456" CI_START="0.27430171581754603" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.100000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.0383240451712795" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.0713720030774194">
<NAME>Pain on non-resisted motion with both hands (VAS:0-100mm)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="9.925698284182456" CI_START="0.27430171581754603" EFFECT_SIZE="5.100000000000001" ESTIMABLE="YES" MEAN_1="22.1" MEAN_2="17.0" ORDER="147003" SD_1="6.01" SD_2="6.01" SE="2.4621362036481016" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.21003174708800376" CI_START="-12.189968252912003" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.042490079104910025" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="13" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.028687998177754">
<NAME>Stiffness both hands (VAS: 0-100mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.21003174708800376" CI_START="-12.189968252912003" EFFECT_SIZE="-6.200000000000003" ESTIMABLE="YES" MEAN_1="24.9" MEAN_2="31.1" ORDER="147004" SD_1="7.46" SD_2="7.46" SE="3.0561624091871606" STUDY_ID="STD-Dellhag-1992" TOTAL_1="13" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" NO="9">
<NAME>Wax bath vs exercises (hand) (End of treatment - 4 wks)*</NAME>
<CONT_OUTCOME CHI2="6.464659953187923E-32" CI_END="-0.044173996376006164" CI_START="-1.7558260036239908" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8999999999999985" ESTIMABLE="YES" I2="100.00000000000001" I2_Q="0.0" ID="CMP-009.01" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.03929075810070189" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.00000000000001" Z="2.061128755864546">
<NAME>Flexion of the dominant hand (ROM deficit in mm, lower score is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.044173996376006386" CI_START="-1.7558260036239908" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="42.9" MEAN_2="43.8" ORDER="147005" SD_1="1.1" SD_2="1.1" SE="0.43665394383500844" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.3541291874726884" CI_START="-23.44587081252731" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.899999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.04337519149159071" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.0200790217330757">
<NAME>Extension of the dominant hand (ROM deficit in mm, lower score is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.3541291874726884" CI_START="-23.44587081252731" EFFECT_SIZE="-11.899999999999999" ESTIMABLE="YES" MEAN_1="21.6" MEAN_2="33.5" ORDER="147006" SD_1="14.84" SD_2="14.84" SE="5.890858660465022" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.034107613668294956" CI_START="-2.1658923863316937" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0999999999999943" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.04310603686048914" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.02268109861808">
<NAME>Grip Function Test (0-80 pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.034107613668294956" CI_START="-2.1658923863316937" EFFECT_SIZE="-1.0999999999999943" ESTIMABLE="YES" MEAN_1="75.0" MEAN_2="76.1" ORDER="147007" SD_1="1.37" SD_2="1.37" SE="0.543832639139965" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.02747045042728169" CI_START="-1.9725295495727182" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.0438705134404502" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.015325894623116">
<NAME>Pinch Function Test (0-32 pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.02747045042728169" CI_START="-1.9725295495727182" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="28.3" MEAN_2="29.3" ORDER="147008" SD_1="1.25" SD_2="1.25" SE="0.49619766344887317" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-13.073498035757972" CI_START="-87.52650196424202" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-50.3" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.008090256557297813" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.00000000000001" Z="2.648279672289968">
<NAME>Grip strength (N) (average dominant hand)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-13.073498035757972" CI_START="-87.52650196424202" EFFECT_SIZE="-50.3" ESTIMABLE="YES" MEAN_1="75.9" MEAN_2="126.2" ORDER="147009" SD_1="6.73" SD_2="62.73" SE="18.99346225638834" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.5878687466735246" CI_START="0.012131253326475466" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.04109601139135016" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.0425600283342393">
<NAME>Pain on resisted motion (0-9pts, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5878687466735246" CI_START="0.012131253326475466" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.3" ORDER="147010" SD_1="0.37" SD_2="0.37" SE="0.14687450838086644" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="17.36489719948094" CI_START="0.4351028005190578" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="8.899999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.039330927565731415" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.0607077736840216">
<NAME>Pain on non-resisted motion with both hands (VAS: 0-100mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.36489719948094" CI_START="0.4351028005190578" EFFECT_SIZE="8.899999999999999" ESTIMABLE="YES" MEAN_1="25.9" MEAN_2="17.0" ORDER="147011" SD_1="10.88" SD_2="10.88" SE="4.318904462658993" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.12429920134672923" CI_START="-8.075700798653273" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.100000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.08" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.04325474846698688" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="2.021241724059388">
<NAME>Stiffness, both hands (VAS: 0-100mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.12429920134672923" CI_START="-8.075700798653273" EFFECT_SIZE="-4.100000000000001" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="31.1" ORDER="147012" SD_1="5.11" SD_2="5.11" SE="2.0284560481789935" STUDY_ID="STD-Dellhag-1992" TOTAL_1="15" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" NO="10">
<NAME>Exercises vs control (Hand) (End of treatment - 4 wks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="-8.195307716986125" CI_START="-28.20469228301388" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-18.200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="3.63216569124908E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="3.565461436449411">
<NAME>Flexion of dominant hand (ROM deficit in mm, lower score is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours</GRAPH_LABEL_2>
<CONT_DATA CI_END="-8.195307716986125" CI_START="-28.20469228301388" EFFECT_SIZE="-18.200000000000003" ESTIMABLE="YES" MEAN_1="43.8" MEAN_2="62.0" ORDER="147013" SD_1="12.46" SD_2="12.46" SE="5.104528635183918" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.32672369196975737" CI_START="-18.47327630803024" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-9.399999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.042301556674234596" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.030541210165811">
<NAME>Extension of dominant hand (ROM deficit in mm, lower score is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.32672369196975737" CI_START="-18.47327630803024" EFFECT_SIZE="-9.399999999999999" ESTIMABLE="YES" MEAN_1="24.1" MEAN_2="33.5" ORDER="147014" SD_1="11.3" SD_2="11.3" SE="4.62930767075267" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.15988714394689" CI_START="0.04011285605309878" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0999999999999943" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.04193733475271252" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.034141460538435">
<NAME>Grip Function Test (0-80 pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.15988714394689" CI_START="0.04011285605309878" EFFECT_SIZE="1.0999999999999943" ESTIMABLE="YES" MEAN_1="76.1" MEAN_2="75.0" ORDER="147015" SD_1="1.32" SD_2="1.32" SE="0.5407686836631438" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.968980962018945E-32" CI_END="0.19635337672244646" CI_START="0.00364662327755641" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.10000000000000143" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-010.04" NO="4" P_CHI2="0.0" P_Q="1.0" P_Z="0.041937334752708486" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.034141460538475">
<NAME>Pinch Function Test (0-32 pts, 0=worst)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.19635337672244646" CI_START="0.003646623277556396" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="29.3" MEAN_2="29.2" ORDER="147016" SD_1="0.12" SD_2="0.12" SE="0.04916078942392216" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.808151762277088E-32" CI_END="47.76204723191536" CI_START="0.8379527680846302" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="24.299999999999994" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-010.05" NO="5" P_CHI2="0.0" P_Q="1.0" P_Z="0.0423601399146888" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.0299645786892904">
<NAME>Grip strength (N) (average of dominant hand)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="47.76204723191536" CI_START="0.8379527680846337" EFFECT_SIZE="24.299999999999997" ESTIMABLE="YES" MEAN_1="109.7" MEAN_2="85.4" ORDER="147017" SD_1="29.22" SD_2="29.22" SE="11.970652224725045" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.968980962018945E-32" CI_END="-0.0072932465551099335" CI_START="-0.39270675344489003" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.19999999999999998" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-010.06" NO="6" P_CHI2="0.0" P_Q="1.0" P_Z="0.04193733475271144" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.0341414605384456">
<NAME>Pain on resisted motion (0-9 pts, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.007293246555109906" CI_START="-0.39270675344489003" EFFECT_SIZE="-0.19999999999999996" ESTIMABLE="YES" MEAN_1="1.3" MEAN_2="1.5" ORDER="147018" SD_1="0.24" SD_2="0.24" SE="0.09832157884784432" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.8520781336730749" CI_START="-31.347921866326928" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-16.1" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.07" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.03850013904038457" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.0694898903424317">
<NAME>Pain on non resisted motion with both hands (VAS: 0-100mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.8520781336730749" CI_START="-31.347921866326928" EFFECT_SIZE="-16.1" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="33.1" ORDER="147019" SD_1="18.99" SD_2="18.99" SE="7.779694926335681" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.296478784805091E-32" CI_END="1.7671803905020074" CI_START="0.03281960949799667" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.900000000000002" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-010.08" NO="8" P_CHI2="0.0" P_Q="1.0" P_Z="0.041937334752711004" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="11" TOTAL_2="13" UNITS="" WEIGHT="100.0" Z="2.03414146053845">
<NAME>Stiffness, both hands (VAS: 0-100mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.7671803905020074" CI_START="0.03281960949799678" EFFECT_SIZE="0.9000000000000021" ESTIMABLE="YES" MEAN_1="31.1" MEAN_2="30.2" ORDER="147020" SD_1="1.08" SD_2="1.08" SE="0.4424471048152995" STUDY_ID="STD-Dellhag-1992" TOTAL_1="11" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" NO="11">
<NAME>Wax vs Ultrasound (Hand) (End of treatment - 1 wk)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="289.3801437879154" CI_START="-253.38014378791542" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="18.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965666219607369" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999975322178295">
<NAME>Hand Grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="289.3801437879154" CI_START="-253.38014378791542" EFFECT_SIZE="18.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="81.0" ORDER="147021" SD_1="309.61" SD_2="309.61" SE="138.46180130274197" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="36.15237539583441" CI_START="-24.152375395834408" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="6.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668597" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.390011856540661">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="36.15237539583441" CI_START="-24.152375395834408" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="314.0" MEAN_2="308.0" ORDER="147022" SD_1="34.4" SD_2="34.4" SE="15.384147685198553" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.0224741575038125" CI_START="-4.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular Index (0-3 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.022474157503813" CI_START="-4.022474157503813" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="10.0" ORDER="147023" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="39.22856309375161" CI_START="-51.22856309375161" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Timed Task (sec.)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="39.22856309375161" CI_START="-51.22856309375161" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="29.0" ORDER="147024" SD_1="51.6" SD_2="51.6" SE="23.076221527797827" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.5996178481286512" CI_START="-0.39961784812865186" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-011.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.6948420111966604" Q="0.0" RANDOM="NO" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39229262763154066">
<NAME>Activity score (checklist, higher score=better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5996178481286512" CI_START="-0.39961784812865186" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="7.7" ORDER="147025" SD_1="0.57" SD_2="0.57" SE="0.254911749434976" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" NO="12">
<NAME>Wax vs Ultrasound (Hand) (End of treatment - 2 wks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="369.22640352774977" CI_START="-323.22640352774977" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="23.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8964070660011362" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13020142653796243">
<NAME>Hand Grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="369.22640352774977" CI_START="-323.22640352774977" EFFECT_SIZE="23.0" ESTIMABLE="YES" MEAN_1="111.0" MEAN_2="88.0" ORDER="147026" SD_1="395.0" SD_2="395.0" SE="176.64937022248338" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="30.129901238330596" CI_START="-20.129901238330596" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965613111696634" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.389966511597452">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="30.129901238330596" CI_START="-20.129901238330596" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="310.0" MEAN_2="305.0" ORDER="147027" SD_1="28.67" SD_2="28.67" SE="12.821613782983794" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.0224741575038125" CI_START="-4.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular Index (0-3 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.022474157503813" CI_START="-4.022474157503813" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="7.0" ORDER="147028" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="45.76665694271022" CI_START="-59.76665694271022" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed Task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="45.76665694271022" CI_START="-59.76665694271022" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="27.0" ORDER="147029" SD_1="60.2" SD_2="60.2" SE="26.92225844909747" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.807618769791721" CI_START="-1.2076187697917196" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.696527780466859" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39001185654066195">
<NAME>Activity score (checklist, higher score=better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.807618769791721" CI_START="-1.2076187697917196" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="9.4" MEAN_2="9.1" ORDER="147030" SD_1="1.72" SD_2="1.72" SE="0.7692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" NO="13">
<NAME>Wax vs Ultrasound (Hand) (End of treatment -3 wks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="353.6848945795843" CI_START="-309.6848945795843" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="22.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965660179597136" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.1300005166485964">
<NAME>Hand Grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="353.6848945795843" CI_START="-309.6848945795843" EFFECT_SIZE="22.0" ESTIMABLE="YES" MEAN_1="111.0" MEAN_2="89.0" ORDER="147031" SD_1="378.41" SD_2="378.41" SE="169.23009667313912" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="36.15237539583441" CI_START="-24.152375395834408" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="6.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668597" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.390011856540661">
<NAME>PIP circumference (mm)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="36.15237539583441" CI_START="-24.152375395834408" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="310.0" MEAN_2="304.0" ORDER="147032" SD_1="34.4" SD_2="34.4" SE="15.384147685198553" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.0224741575038125" CI_START="-4.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular Index (0-3 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.022474157503813" CI_START="-4.022474157503813" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="5.0" ORDER="147033" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="44.78882175124842" CI_START="-2.788821751248424" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="21.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.08359586764049923" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="1.7301926133933525">
<NAME>ROM (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="44.78882175124842" CI_START="-2.788821751248424" EFFECT_SIZE="21.0" ESTIMABLE="YES" MEAN_1="90.0" MEAN_2="69.0" ORDER="147034" SD_1="27.14" SD_2="27.14" SE="12.137376981868858" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="45.76665694271022" CI_START="-59.76665694271022" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed Task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="45.76665694271022" CI_START="-59.76665694271022" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="18.0" MEAN_2="25.0" ORDER="147035" SD_1="60.2" SD_2="60.2" SE="26.92225844909747" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.208000921663068" CI_START="-0.8080009216630695" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.6973638922025724" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.38888138739126643">
<NAME>Activity score (checklist, higher score=better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.208000921663068" CI_START="-0.8080009216630695" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="10.0" ORDER="147036" SD_1="1.15" SD_2="1.15" SE="0.5142956348249516" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-014" NO="14">
<NAME>Faradic bath vs Control (Hand) (End of treatment - 1 wk)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="176.846829902495" CI_START="-154.846829902495" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="11.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-014.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965687359089269" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999708129854495">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="176.84682990249502" CI_START="-154.84682990249502" EFFECT_SIZE="11.0" ESTIMABLE="YES" MEAN_1="92.0" MEAN_2="81.0" ORDER="147037" SD_1="189.21" SD_2="189.21" SE="84.61728440454705" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="162.68568928125484" CI_START="-108.68568928125484" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="27.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-014.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668598" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39001185654066095">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="162.68568928125484" CI_START="-108.68568928125484" EFFECT_SIZE="27.0" ESTIMABLE="YES" MEAN_1="335.0" MEAN_2="308.0" ORDER="147038" SD_1="154.8" SD_2="154.8" SE="69.2286645833935" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="11.625697877208726" CI_START="-7.625697877208726" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-014.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6838348727201189" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="12" UNITS="" WEIGHT="100.0" Z="0.40723571621352556">
<NAME>Articular Index (0-3 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="11.625697877208728" CI_START="-7.625697877208728" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="10.0" ORDER="147039" SD_1="11.47" SD_2="11.47" SE="4.911160589242968" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="52.304750791668816" CI_START="-68.30475079166882" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-8.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-014.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Time Task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="52.304750791668816" CI_START="-68.30475079166882" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="21.0" MEAN_2="29.0" ORDER="147040" SD_1="68.8" SD_2="68.8" SE="30.768295370397105" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.291409808908074E-34" CI_END="7.687484832727969" CI_START="-6.687484832727971" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.49999999999999906" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-014.05" NO="5" P_CHI2="0.0" P_Q="1.0" P_Z="0.8915480702603948" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13634560838413326">
<NAME>Activity score (checklist, higher score=better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.687484832727969" CI_START="-6.687484832727971" EFFECT_SIZE="0.4999999999999991" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="7.7" ORDER="147041" SD_1="8.2" SD_2="8.2" SE="3.667151483099655" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-015" NO="15">
<NAME>Faradic bath vs Control (Hand) (End of treatment - 2 wks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="112.53331388542044" CI_START="-98.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-015.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965632998680593" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13000395218022032">
<NAME>Hand Grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="112.53331388542044" CI_START="-98.53331388542044" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="95.0" MEAN_2="88.0" ORDER="147042" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="156.66321512375103" CI_START="-104.66321512375103" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="26.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-015.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965342292384706" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3900031355403135">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="156.66321512375103" CI_START="-104.66321512375103" EFFECT_SIZE="26.0" ESTIMABLE="YES" MEAN_1="331.0" MEAN_2="305.0" ORDER="147043" SD_1="149.07" SD_2="149.07" SE="66.66613068117873" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="18.076187697917206" CI_START="-12.076187697917204" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-015.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668597" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.390011856540661">
<NAME>Articular Index (0-3 scale, 0=pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="18.076187697917206" CI_START="-12.076187697917204" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="7.0" ORDER="147044" SD_1="17.2" SD_2="17.2" SE="7.692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="45.76665694271022" CI_START="-59.76665694271022" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-015.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed Task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="45.76665694271022" CI_START="-59.76665694271022" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="27.0" ORDER="147045" SD_1="60.2" SD_2="60.2" SE="26.92225844909747" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.5804872129845069" CI_START="0.01951278701549458" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-015.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.036054369667859125" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="2.0963137289060576">
<NAME>Activity score (checklist, higher score=better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5804872129845069" CI_START="0.01951278701549458" EFFECT_SIZE="0.3000000000000007" ESTIMABLE="YES" MEAN_1="9.4" MEAN_2="9.1" ORDER="147046" SD_1="0.32" SD_2="0.32" SE="0.14310835055998655" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-016" NO="16">
<NAME>Faradic bath vs Control (Hand) (End of treatment - 3 wks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="160.7706422045778" CI_START="-140.7706422045778" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="10.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965692794816777" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999639425032206">
<NAME>Hand Grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="160.7706422045778" CI_START="-140.7706422045778" EFFECT_SIZE="10.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="89.0" ORDER="147047" SD_1="172.01" SD_2="172.01" SE="76.92521056194776" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="150.64074096624722" CI_START="-100.64074096624722" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="25.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965411936125214" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3899937172979959">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="150.64074096624722" CI_START="-100.64074096624722" EFFECT_SIZE="25.0" ESTIMABLE="YES" MEAN_1="329.0" MEAN_2="304.0" ORDER="147048" SD_1="143.34" SD_2="143.34" SE="64.10359677896398" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="30.129901238330596" CI_START="-20.129901238330596" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965613111696634" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.389966511597452">
<NAME>Articular Index (0-3) scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="30.129901238330596" CI_START="-20.129901238330596" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="5.0" ORDER="147049" SD_1="28.67" SD_2="28.67" SE="12.821613782983794" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="17.063243069561853" CI_START="-1.063243069561853" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="8.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.08362433451904365" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="1.7300332514505143">
<NAME>ROM (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.063243069561853" CI_START="-1.063243069561853" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="77.0" MEAN_2="69.0" ORDER="147050" SD_1="10.34" SD_2="10.34" SE="4.624188577469565" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="32.690469244793015" CI_START="-42.690469244793015" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.26000790436044063">
<NAME>Timed Task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="32.690469244793015" CI_START="-42.690469244793015" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="25.0" ORDER="147051" SD_1="43.0" SD_2="43.0" SE="19.23018460649819" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.09039889400431811" CI_START="-2.5096011059956833" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-016.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.035166076183242655" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.1064408483693686">
<NAME>Activity score (checklist, higher score=better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.09039889400431811" CI_START="-2.5096011059956833" EFFECT_SIZE="-1.3000000000000007" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="10.0" ORDER="147052" SD_1="1.38" SD_2="1.38" SE="0.6171547617899419" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-017" NO="17">
<NAME>Wax vs Faradic bath +Ultrasound (Hand) ( End of treatment - 1 week)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="112.53331388542044" CI_START="-98.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="7.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-017.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965632998680593" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13000395218022032">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="112.53331388542044" CI_START="-98.53331388542044" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="92.0" ORDER="147053" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="84.53331388542044" CI_START="-126.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-21.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-017.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668598" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39001185654066095">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="84.53331388542044" CI_START="-126.53331388542044" EFFECT_SIZE="-21.0" ESTIMABLE="YES" MEAN_1="314.0" MEAN_2="335.0" ORDER="147054" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="4.0224741575038125" CI_START="-6.0224741575038125" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-017.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6963600188246013" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.00000000000001" Z="0.39023873952875915">
<NAME>Articular index (0-3 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.022474157503813" CI_START="-6.022474157503813" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="12.0" ORDER="147055" SD_1="5.73" SD_2="5.73" SE="2.562533902214759" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="17.076187697917206" CI_START="-13.076187697917204" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-017.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.076187697917206" CI_START="-13.076187697917204" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="21.0" ORDER="147056" SD_1="17.2" SD_2="17.2" SE="7.692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.0230953075520694" CI_START="-0.7769046924479295" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.39999999999999947" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-017.05" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.037519733212751476" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.0800632348835224">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.0230953075520694" CI_START="-0.7769046924479295" EFFECT_SIZE="-0.39999999999999947" ESTIMABLE="YES" MEAN_1="7.8" MEAN_2="8.2" ORDER="147057" SD_1="0.43" SD_2="0.43" SE="0.1923018460649819" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-018" NO="18">
<NAME>Wax vs Faradic bath + Ultrasound (Hand) (End of treatment - 2 weeks)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="257.22776839208103" CI_START="-225.22776839208103" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="16.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-018.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.8965670372073602" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.12999922837104988">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="257.22776839208103" CI_START="-225.22776839208103" EFFECT_SIZE="16.0" ESTIMABLE="YES" MEAN_1="111.0" MEAN_2="95.0" ORDER="147058" SD_1="275.21" SD_2="275.21" SE="123.07765361754342" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="84.53331388542044" CI_START="-126.53331388542044" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-21.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-018.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965277804668598" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.39001185654066095">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="84.53331388542044" CI_START="-126.53331388542044" EFFECT_SIZE="-21.0" ESTIMABLE="YES" MEAN_1="310.0" MEAN_2="331.0" ORDER="147059" SD_1="120.4" SD_2="120.4" SE="53.84451689819494" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="8.05371354041339" CI_START="-12.05371354041339" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-018.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6966115937183786" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3898985139493967">
<NAME>Articular index (0-3 scale, 0=no pain)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.053713540413392" CI_START="-12.053713540413392" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="10.0" ORDER="147060" SD_1="11.47" SD_2="11.47" SE="5.129539940384518" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-018.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="20.0" MEAN_2="20.0" ORDER="147061" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-018.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="9.4" MEAN_2="9.4" ORDER="147062" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-019" NO="19">
<NAME>Wax vs Faradic bath + Ultrasound (Hand) (End of treatment - 3 weeks)*</NAME>
<CONT_OUTCOME CHI2="3.71788531068438E-34" CI_END="192.56364335877583" CI_START="-168.56364335877583" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="11.999999999999998" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-019.01" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.8963635841505456" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.13025638703882267">
<NAME>Hand grip (mmHg)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="192.56364335877583" CI_START="-168.56364335877583" EFFECT_SIZE="12.0" ESTIMABLE="YES" MEAN_1="111.0" MEAN_2="99.0" ORDER="147063" SD_1="206.0" SD_2="206.0" SE="92.12600067299134" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="76.48836557041281" CI_START="-114.48836557041281" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-19.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-019.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6965454291032337" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3899879894666422">
<NAME>PIP circumference (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="76.48836557041281" CI_START="-114.48836557041281" EFFECT_SIZE="-19.0" ESTIMABLE="YES" MEAN_1="310.0" MEAN_2="329.0" ORDER="147064" SD_1="108.94" SD_2="108.94" SE="48.71944909376542" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="16.098661855421017" CI_START="-24.098661855421017" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-019.03" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6964858569552868" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.3900685525512062">
<NAME>Articular index (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="16.098661855421017" CI_START="-24.098661855421017" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="10.0" ORDER="147065" SD_1="22.93" SD_2="22.93" SE="10.254607744814036" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="13.076187697917204" CI_START="-17.076187697917206" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-019.04" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.794857676708056" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.2600079043604407">
<NAME>Timed task (sec)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="13.076187697917204" CI_START="-17.076187697917206" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="18.0" MEAN_2="20.0" ORDER="147066" SD_1="17.2" SD_2="17.2" SE="7.692073842599276" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.629649721936177E-32" CI_END="2.9024360649225307" CI_START="0.09756393507746886" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.4999999999999998" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-019.05" NO="5" P_CHI2="0.0" P_Q="1.0" P_Z="0.0360543696678596" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="2.0963137289060523">
<NAME>Activity score (checklist, higher is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.902436064922531" CI_START="0.09756393507746908" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="8.7" ORDER="147067" SD_1="1.6" SD_2="1.6" SE="0.7155417527999328" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="27.72557868168657" CI_START="-1.7255786816865708" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="13.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-019.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.08357835085621296" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="1.7302906968748373">
<NAME>ROM (mm)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="27.72557868168657" CI_START="-1.7255786816865708" EFFECT_SIZE="13.0" ESTIMABLE="YES" MEAN_1="90.0" MEAN_2="77.0" ORDER="147068" SD_1="16.8" SD_2="16.8" SE="7.513188404399293" STUDY_ID="STD-Hawkes-1986" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-020" NO="20">
<NAME>Cryotherapy vs Control (Hand) (End of treatment-2 days)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.18306521659017339" CI_START="-11.783065216590174" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-020.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.05743383909397391" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" UNITS="" WEIGHT="100.0" Z="1.8999945176614617">
<NAME>% of change in post-surgery oedema increase (lower is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.18306521659017339" CI_START="-11.783065216590174" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="16.3" MEAN_2="22.1" ORDER="147069" SD_1="8.36" SD_2="8.36" SE="3.0526403871621257" STUDY_ID="STD-Rembe-1970" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-021" NO="21">
<NAME>Cryotherapy vs Control (Hand) (End of treatment-3 days)*</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.3125253002893764" CI_START="-19.912525300289374" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-9.799999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-021.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.057512988429908984" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" UNITS="" WEIGHT="100.0" Z="1.8993917422330597">
<NAME>% of change in post-surgery oedema increase (lower % is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3125253002893764" CI_START="-19.912525300289374" EFFECT_SIZE="-9.799999999999999" ESTIMABLE="YES" MEAN_1="12.1" MEAN_2="21.9" ORDER="147070" SD_1="14.13" SD_2="14.13" SE="5.1595464916986655" STUDY_ID="STD-Rembe-1970" TOTAL_1="15" TOTAL_2="15" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-022" NO="22">
<NAME>Cryotherapy vs Control (Hand) (End of treatment-4 days)*</NAME>
<CONT_OUTCOME CHI2="6.990142709307171E-32" CI_END="0.023029306109891512" CI_START="-1.6230293061098933" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8000000000000008" ESTIMABLE="YES" I2="99.99999999999999" I2_Q="0.0" ID="CMP-022.01" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.05676422217340371" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="15" UNITS="" WEIGHT="99.99999999999999" Z="1.9051219391484058">
<NAME>% of change in post-surgery oedema increase (lower % is better)*</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.023029306109891623" CI_START="-1.623029306109893" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="17.8" ORDER="147071" SD_1="1.15" SD_2="1.15" SE="0.41992062742062736" STUDY_ID="STD-Rembe-1970" TOTAL_1="15" TOTAL_2="15" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-11-09 19:52:01 -0500" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-11-09 19:52:01 -0500" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-11-09 19:51:59 -0500" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-09 19:52:01 -0500" MODIFIED_BY="[Empty name]">
<P>1 exp osteoarthritis/<BR/>2 osteoarthritis.tw.<BR/>3 osteoarthrosis.tw.<BR/>4 degenerative arthritis.tw.<BR/>5 exp arthritis, rheumatoid/<BR/>6 rheumatoid arthritis.tw.<BR/>7 rheumatism.tw.<BR/>8 arthritis, juvenile rheumatoid/<BR/>9 caplan's syndrome.tw.<BR/>10 felty's syndrome.tw.<BR/>11 rheumatoid.tw.<BR/>12 ankylosing spondylitis.tw.<BR/>13 arthrosis.tw.<BR/>14 sjogren$.tw.<BR/>15 or/1-14<BR/>16 heat/tu<BR/>17 (heat or hot or ice).tw.<BR/>18 cryotherapy.sh,tw.<BR/>19 (vapocoolant or phonophoresis).tw.<BR/>20 exp hyperthermia, induced/<BR/>21 (hypertherm$ or thermotherapy).tw.<BR/>22 (fluidotherapy or compression).tw.<BR/>23 15 and 22<BR/>24 clinical trial.pt.<BR/>25 randomized controlled trial.pt.<BR/>26 tu.fs.<BR/>27 dt.fs.<BR/>28 random$.tw.<BR/>29 placebo$.tw.<BR/>30 ((sing$ or doubl$ or tripl$) adj (masked or blind$)).tw<BR/>31 sham.tw.<BR/>32 or/24-31<BR/>33 23 and 32</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>